Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients
Abstract Apixaban is frequently used off‐label in transplant recipients. However, a potential drug interaction exists with the calcineurin inhibitors. We conducted an open‐label drug–drug interaction study to determine the pharmacokinetics of apixaban in lung and kidney transplant recipients who wer...
Main Authors: | Holly Mansell, Ahmed Shoker, Jane Alcorn, Mark E. Fenton, Julian S. Tam, William Semchuk, Babar Bashir, Walter K. Kraft, Shenzhen Yao, James D. Douketis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-07-01
|
Series: | Clinical and Translational Science |
Online Access: | https://doi.org/10.1111/cts.13284 |
Similar Items
-
Effect of cyclosporin and tacrolimus on kidney function in liver recipients
by: Elena D. Kosmacheva, et al.
Published: (2018-09-01) -
Pharmacokinetics and Pharmacogenetics of Apixaban
by: A. V. Savinova, et al.
Published: (2020-11-01) -
Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants
by: Seung Seok Han, et al.
Published: (2012-09-01) -
COMPARATIVE ANALYSIS OF SOLUBLE OF CD40 LIGAND LEVELS IN HEART RECIPIENTS TREATED WITH CYCLOSPORINE A AND TACROLIMUS
by: O. P. Shevchenko, et al.
Published: (2012-05-01) -
Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.
by: Ammon Handisurya, et al.
Published: (2016-01-01)